Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,360 | 16,293 | 51,162 | 58,338 | 240,420 |
| Marketable Securities | 126,980 | 193,244 | 277,665 | 189,325 | 135,412 |
| Receivables | 1,973 | 2,093 | 2,434 | 2,417 | 6,636 |
| Other current assets | 1,006 | 1,158 | 1,425 | 2,247 | 1,488 |
| TOTAL | $145,232 | $219,377 | $338,841 | $260,248 | $391,192 |
| Non-Current Assets | |||||
| PPE Net | 6,760 | 19,281 | 18,270 | 10,678 | 4,887 |
| Investments And Advances | 3,505 | 49,125 | 51,330 | 77,071 | 45,302 |
| Other Non-Current Assets | 19,870 | 25,530 | 23,768 | 25,768 | 975 |
| TOTAL | $30,135 | $93,936 | $93,368 | $113,517 | $51,164 |
| Total Assets | $175,367 | $313,313 | $432,209 | $373,765 | $442,356 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,783 | 2,476 | 3,120 | 1,146 | 3,990 |
| Accrued Expenses | 16,535 | 23,620 | 21,135 | 16,079 | 13,136 |
| TOTAL | $25,414 | $30,651 | $28,302 | $28,128 | $25,829 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,895 | 3,129 | 2,847 | 9,937 | 8,703 |
| Other Non-Current Liabilities | 26,026 | 25,846 | 28,847 | 28,431 | 6,194 |
| TOTAL | $27,778 | $29,711 | $35,506 | $44,766 | $28,702 |
| Total Liabilities | $53,192 | $60,362 | $63,808 | $72,894 | $54,531 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,637 | 93,005 | 90,315 | 61,300 | 60,664 |
| Common Shares | 9 | 9 | 8 | 6 | 6 |
| Retained earnings | -596,515 | -448,390 | -299,285 | -197,215 | -97,794 |
| Other shareholders' equity | 103 | 255 | 30 | -1,518 | -135 |
| TOTAL | $122,175 | $252,951 | $368,401 | $300,871 | $387,825 |
| Total Liabilities And Equity | $175,367 | $313,313 | $432,209 | $373,765 | $442,356 |